MedAdvisor Limited (MDR.AX)
AUD 0.09
(-1.05%)
AUD 0.09
(-1.05%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 7.04 Million AUD | 332.74% |
| 2023 | -3.02 Million AUD | 79.06% |
| 2022 | -11.28 Million AUD | 25.25% |
| 2021 | -14.92 Million AUD | -42.19% |
| 2020 | -10.34 Million AUD | -30.97% |
| 2019 | -7.82 Million AUD | -77.42% |
| 2018 | -4.24 Million AUD | -34.24% |
| 2017 | -3.4 Million AUD | -18.15% |
| 2016 | -2.88 Million AUD | -334.55% |
| 2015 | -666 Thousand AUD | 94.04% |
| 2014 | -11.13 Million AUD | -205.05% |
| 2013 | -3.74 Million AUD | -227.62% |
| 2012 | -993.25 Thousand AUD | -1077.6% |
| 2011 | -94.51 Thousand AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - AUD | 391.56% |
| 2024 Q4 | -5.11 Million AUD | 0.0% |
| 2024 Q2 | 10.33 Million AUD | 0.0% |
| 2023 Q2 | 8.56 Million AUD | 0.0% |
| 2023 FY | - AUD | 79.06% |
| 2023 Q4 | -11.63 Million AUD | 0.0% |
| 2022 FY | - AUD | 25.25% |
| 2022 Q2 | -4.51 Million AUD | 0.0% |
| 2022 Q4 | -6.77 Million AUD | 0.0% |
| 2021 FY | - AUD | -42.19% |
| 2021 Q4 | -7.79 Million AUD | 0.0% |
| 2021 Q2 | -6.44 Million AUD | 0.0% |
| 2020 FY | - AUD | -30.97% |
| 2020 Q4 | -5.52 Million AUD | 0.0% |
| 2020 Q2 | -5.09 Million AUD | 0.0% |
| 2019 Q2 | -4.45 Million AUD | 0.0% |
| 2019 FY | - AUD | -77.42% |
| 2019 Q4 | -3.65 Million AUD | 0.0% |
| 2018 Q2 | -2.2 Million AUD | 0.0% |
| 2018 FY | - AUD | -34.24% |
| 2018 Q4 | -2.36 Million AUD | 0.0% |
| 2017 Q2 | -1.96 Million AUD | 0.0% |
| 2017 FY | - AUD | -18.15% |
| 2017 Q4 | -1.43 Million AUD | 0.0% |
| 2016 FY | - AUD | -334.55% |
| 2016 Q2 | -922.01 Thousand AUD | 0.0% |
| 2016 Q4 | -1.95 Million AUD | 0.0% |
| 2015 FY | - AUD | 94.04% |
| 2015 Q1 | -2.78 Million AUD | 0.0% |
| 2015 Q3 | -165.78 Thousand AUD | 43.48% |
| 2015 Q4 | -255.05 Thousand AUD | -53.84% |
| 2015 Q2 | -293.33 Thousand AUD | 89.45% |
| 2014 Q3 | -2.78 Million AUD | 0.0% |
| 2014 FY | - AUD | -205.05% |
| 2014 Q4 | -2.78 Million AUD | 0.0% |
| 2014 Q2 | -2.78 Million AUD | -196.97% |
| 2014 Q1 | -936.39 Thousand AUD | 0.0% |
| 2013 Q3 | -936.39 Thousand AUD | 0.0% |
| 2013 Q4 | -936.39 Thousand AUD | 0.0% |
| 2013 Q2 | -936.39 Thousand AUD | -277.1% |
| 2013 Q1 | -248.31 Thousand AUD | 0.0% |
| 2013 FY | - AUD | -227.62% |
| 2012 FY | - AUD | -1077.6% |
| 2012 Q1 | -17.55 Thousand AUD | 0.0% |
| 2012 Q2 | -248.31 Thousand AUD | -1314.31% |
| 2012 Q3 | -248.31 Thousand AUD | 0.0% |
| 2012 Q4 | -248.31 Thousand AUD | 0.0% |
| 2011 Q1 | - AUD | 0.0% |
| 2011 FY | - AUD | 0.0% |
| 2011 Q4 | -17.55 Thousand AUD | 0.0% |
| 2011 Q2 | -17.55 Thousand AUD | 0.0% |
| 2011 Q3 | -17.55 Thousand AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 Q2 | - AUD | 0.0% |
| 2010 Q3 | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Alcidion Group Limited | -4.49 Million AUD | 256.768% |
| Artrya Limited | -13.95 Million AUD | 150.507% |
| Beamtree Holdings Limited | -331 Thousand AUD | 2229.397% |
| Cogstate Limited | 9.89 Million AUD | 28.742% |
| Careteq Limited | -826.61 Thousand AUD | 952.67% |
| Doctor Care Anywhere Group PLC | -8.35 Million AUD | 184.37% |
| Emyria Limited | -13.03 Million AUD | 154.073% |
| Global Health Limited | -1.76 Million AUD | 499.162% |
| HITIQ Limited | -2.54 Million AUD | 377.206% |
| Intelicare Holdings Limited | -3.02 Million AUD | 333.347% |
| ImExHS Limited | -1.25 Million AUD | 660.403% |
| Mach7 Technologies Limited | -2.44 Million AUD | 388.624% |
| Oakridge International Limited | -630.05 Thousand AUD | 1218.684% |
| Opyl Limited | -3.2 Million AUD | 319.625% |
| PainChek Limited | -9.48 Million AUD | 174.283% |
| Pro Medicus Limited | 120.76 Million AUD | 94.163% |
| Resonance Health Limited | -457 Thousand AUD | 1642.271% |
| Singular Health Group Ltd | -2.88 Million AUD | 344.297% |
| Total Brain Limited | -5.49 Million AUD | 228.358% |